COMP <GO>
RYZ vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Ryerson Holding Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: RYZ 2
— TMO 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $31.00 (+4.48%) • MKT CAP: $1.60B
roic
-3.40%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RYZ VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RYZ | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 17.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -3.40% | 9.30% | -12.70 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 2.40% | -0.19 | TMO | /fcf-yield <GO> |
| Operating Margin | -0.70% | 17.40% | -18.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | -1.20% | 15.10% | -16.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -0.60% | 3.90% | -4.50 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.50% | 0.24% | +1.26 | RYZ | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.13 | 4.50 | -1.37 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 79.9 | 62.9 | +16.99 | RYZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.60B | $262.22B | -$260.61B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RYZ REV | TMO REV | RYZ GROSS % | TMO GROSS % | RYZ FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.57B | $44.56B | 17.1% | — | $35.5M | $6.29B |
| FY 2024 | $4.60B | $42.88B | 18.1% | — | $105.3M | $7.27B |
| FY 2023 | $5.11B | $42.86B | — | — | $365.1M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RYZ // BETA —
TMO // BETA 0.94